Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Acasti Pharma Inc. logo

Acasti Pharma Inc.

Sector: Healthcare   

Industry: Biotechnology

2.77
 
USD
  
0.36
  
(14.94%)
Optionable: No  Market Cap: 18 M  90-day average vol: 56,036

Previous close: 2.41  Open: 2.5  Bid: 2.77  Ask: 2.86
52 week range    
0.52   
   5.05
Peers   
OPHLY / 
ONCX / 
Last updated: Thursday 28th September 2023
61
MarketXLS Rank
60
Value
92
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

OMER

0 B-36.79

ONCX

OPHLY

Financials

ACST Income Statement

Annual
Invalid dateMar-20Mar-21Mar-22Mar-23
Basic EPS from continuing operations-2.4-10640.0-0.27-0.95
Basic EPS total-2.4-10640.0-0.27-0.95
Basic weighted shares outstanding11 M1,854 M37 M45 M
Cost of sales76000.0
Depreciation8000.0
Depreciation unreconciled8000.0
DepreciationAndAmortization8000.0
Diluted EPS total-2.4-10640.0-0.27-0.95
Diluted normalized net income/share-2.4-10640.0-0.27-0.95
Diluted weighted shares outstanding11 M1,854 M37 M45 M
GainOnSaleOfSecurity-1 M-3 M
GeneralAndAdministrativeExpense6 M6 M9 M8 M
Gross operating profit120000.0
ImpairmentOfCapitalAssets6 M249000.0
Income before tax-26 M-20 M-10 M-52 M
Income taxes-648000.0-10 M
Interest income336000.0-107000.0224000.0246000.0
InterestExpenseNonOperating1 M
MiscOtherSpecialCharges147000.0
Net income from total operations-26 M-20 M-9 M-42 M
NetIncomeCommonStockholders-26 M-20 M-9 M-42 M
NetIncomeContinuousOperations-26 M-20 M-9 M-42 M
NetNonOperatingInterestIncomeExpense-1 M-107000.0224000.0246000.0
Normalized income-19 M-9 M-10 M-28 M
Operating income-24 M-11 M-15 M-18 M
Operating income before depreciation (EBITDA)-22 M-19 M-10 M-52 M
OperatingExpense24 M11 M15 M18 M
Other income net-1 M3 M-5 M34 M
OtherGandA6 M6 M9 M8 M
OtherImpairmentOfCapitalAssets249000.034 M
OtherWriteOff264000.0
Research & development expense16 M4 M6 M10 M
ResearchExpense16 M4 M6 M10 M
SalariesAndWages3 M2 M
Selling Gen & administrative expense8 M7 M10 M8 M
SellingAndMarketingExpense3 M1 M518000.0661000.0
Special income/charges-6 M-249000.0
Total Income available for interest expense (EBIT)-24 M-20 M-10 M-52 M
Total net income-26 M-20 M-9 M-42 M
Total ordinary shares7 M7 M7 M7 M
Total revenues196000.0
TotalExpenses-24 M-11 M15 M18 M
TotalRevenue196000.0
WriteOff413000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today